R eperfusion is so central to the modern treatment of acute ST-elevation myocardial infarction (STEMI) that we are said to be in the reperfusion era. Many studies have shown a significant relationship between time-to-treatment resulting in reperfusion and mortality.
Clinical

Rural acute myocardial infarction survey (RAMIS)
R eperfusion is so central to the modern treatment of acute ST-elevation myocardial infarction (STEMI) that we are said to be in the reperfusion era. Many studies have shown a significant relationship between time-to-treatment resulting in reperfusion and mortality.
There are two main strategies to achieve reperfusion: thrombolytic therapy and percutaneous coronary intervention (PCI). Over the last 40 years the mantra 'time is muscle' has been popularised to describe the urgency of identifying and treating myocardial infarctions. In those early days of EMS it was thought that the treatment should happen within three hours of onset. Later treatment guidelines focused on treatment within two hours but suggested a 'golden hour' was even better. Although many historical studies have concluded with conflicting results, more recent data demonstrates that a shorter time-to-reperfusion will result in improved cardiac function.
In 2004, the American College of Cardiology (ACC)/American Heart Association (AHA) STEMI guidelines were updated to suggest the goal for stent or balloon angioplasty (also known as D2B or door-to-balloon time) of ≤ 90 minutes for at least 75 % of non-transfer PCI patients with STEMI in all participating hospitals performing primary PCI, while clot-busting medications should be given in 30 minutes (also known as D2N or door-to-needle time) to patients who do not have significant risk factors for bleeding issues. At the time, only 25 % of cardiac catheterisation labs were achieving D2B times of 92 minutes while less than 5 % of patients transferred from other hospitals were seeing D2B times of less than 90 minutes.
In 2006, fewer than half of hospitals were capable of performing PCI within the recommended 90 minute D2B guideline. The fact that comparatively few hospitals were meeting the established guidelines prompted the ACC to launch the D2B Alliance and the AHA to launch Mission: Lifeline (M:L) to support development of Please rate how critical the following issues may be in rapidly identifying and treating STEMI patients in your community These combined efforts have been very effective at reducing the D2B and D2N times for patients across the country, particularly those in suburban and urban areas, who have immediate access to interventional cardiac catheterisation (cath) labs. By the end of 2010, more than 90 % of hospitals were achieving D2B times < 90 minutes with a median time of 64 minutes. These gains in reducing the time to reperfusion are credited in large part to the gathering of evidence and sharing of best practices.
Clinical
The main factors behind delays at the referral hospitals for those without immediate access to PCI were caused by: awaiting transportation (26 %), emergency department delays (14 %), diagnostic dilemma (9 %), initial negative test for heart attack (9 %), and cardiac arrest (6 %).
Bradley et al discovered that best practice strategies of a single-call system of activation and the use of pre-hospital electrocardiograms while the patient is en route to the hospitals were used by less than one third of hospitals surveyed. Given the strong evidence of the impact of these strategies on D2B times and the persistent underuse of effective strategies, there remains tremendous opportunity to improve quality of care and reduce mortality for patients with STEMI .
Bradley et al also concluded that: (Bradley et al, 2008) Comparatively, less attention has been paid to STEMI patients who report to non-PCI hospitals, particularly in rural environments. In the rural setting, it is often not possible to get patients to a cath lab within 90 minutes of first medical contact, making thrombolytic therapy the preferred initial therapy. However, thrombolytic therapy requires an extensive review of contraindications, leaving many patients ineligible.
In addition, studies have shown that thrombolytic therapy will be ineffective up to 30 % of the time Clinical (< 50 % resolution of ST-elevation 90 minutes following thrombolytic therapy). It therefore seems reasonable to transfer all STEMI patients to PCI centers regardless of the initial strategy chosen as some will require 'rescue PCI'.
Recent studies, have shown that a small minority of non-PCI hospitals are capable of achieving 'door-in' to 'door-out' (DIDO) times of less than 30 minutes, and that mortality is higher when transfer times are delayed. In addition, it is not clear that non-PCI hospitals routinely achieve D2N times of less than 30 minutes when thrombolytic therapy is selected as the primary reperfusion strategy.
We hypothesised that STEMI patients in the rural setting may not be receiving timely reperfusion in the State of Nebraska. Nebraska is served by 65 CAHs that are not in suburban communities and most are more than an hour drive from the closest cath lab. We also sought to better understand the resources, capabilities, and challenges of Nebraska's 65 CAHs and identify whether Nebraska myocardial infarction patients receive timely reperfusion in accordance with current guidelines and best practices.
Methods
We conducted a quantitative study using a structured web-based survey (see Table 1 1) were received from all 65 CAHs collectively representing 1 346 hospital beds or 27 % of the statewide adult acute care capacity, of which 76 % of the surveys were completed by RNs, 7 % by MDs, 5 % by NREMT-Bs, 4 % by PAs and NREMT-Ps, 3 % by NPs, and 1 % by DOs. These CAH respondents reported seeing a mean of 7.8 STEMI, 12.4 NSTEMI, 8.9 stroke, and 40.9 trauma patients in calendar year 2010. Local EMS responders perform 12-lead acquisition 16.9 % of the time (11: Yes, 50: No, 2: Uncertain), 12-lead interpretation 7.7 % (5 yes, 54 no, 5 uncertain), transmit 12-leads to CAH for interpretation during an EMS call 3 % (2: Yes, 59: No, 3: Uncertain), and transmit 12-leads to regional STEMI center for interpretation during an EMS call in one location (1: Yes, 60: No, 3: Uncertain).
The results of the survey showed that although the vast majority of critical access hospitals were capable of giving thrombolytic therapy, a significant number elected to transfer patients to a PCI center without giving thrombolytic therapy.
Clinical
Therefore, a series of follow-up questions were asked through a selective telephone survey to determine the reason that primary PCI was selected as the reperfusion strategy. The results of the second survey showed the perceived benefits of a statewide coordinated approach to STEMI care from the CAH representatives. The following comments were also received by the project team while discussing regional issues with CAH representatives but were not components of the survey itself:
1. Overwhelmingly, Critical Access Hospitals report the reperfusion strategy is decided by the receiving cardiologist at the PCI-hospital: 
Discussion
This study is the first to examine the reasons why thrombolytic therapy is not given to eligible patients in rural Nebraska when transfer times are prolonged.
We found that receiving cardiologists are considering the time of onset of symptoms and the expected transfer time prior to selecting the reperfusion strategy but are underestimating the total time from first-medical-contact to reperfusion, primarily due to the time required to arrange for and conduct an interfacility transfer to the PCI center from a CAH.
To better illustrate the components of this rural treatment plus interfacility interval, consider the following elements: l Patient recognises symptoms l Initial 9-1-1 call, EMS response, and transport l Arrival of the patient at the Critical Access Hospital (EMS or walk-in) l Diagnosis of acute STEMI (physician, PA or NP is 'on-call' during off hours) l Consultation with cardiologist at PCI hospital (sometimes only occurring after results of cardiac biomarkers are available) l Selection of transfer mode (ground or air ambulance) l Preparation (duplication) of medical records, X-rays, lab tests for PCI center l Reaction time of ground or air ambulance to the CAH l Transition time while report is given and patient is loaded for transport l Travel time from CAH to PCI center l Arrival at PCI-hospital (including in house processes for intake) l D2B at PCI-hospital This study did not consider the timeliness of thrombolytic therapy at CAHs when thrombolytic therapy is chosen as the initial or primary reperfusion strategy. Since virtually all STEMI patients (with very few exceptions) are ultimately transferred out of CAHs and the cardiologist at the receiving hospital selects the reperfusion strategy it is likely that D2N times exceed the recommended 30 minutes.
With a focus on reducing the first-medical-contact to reperfusion time there are additional aspects of the EMS, CAH, PCI center STEMI care system that could be addressed. For example, we found that:
1 
Conclusion
We qualitatively demonstrated that STEMI patients in the rural setting of Nebraska are not receiving timely reperfusion, and that even data describing the number of persons and delays experienced are not widely tracked. Although currently lacking, individuals surveyed expressed a desire for a statewide coordinated STEMI care system. Furthermore, the reasons why there are DIDO delays or policies not allowing EMTs to acquire a diagnostic 12-lead EKG or bypass a CAH hospital, were reasons mostly revolving around issues in which very basic education of both the staff at the CAH and the receiving cardiologists could mitigate further patient delays and improve treatment.
